I said they are interested in "trials"; another term is "interventional studies". So studies that measured post-exertional symptoms before and after a treatment of any sort, most likely a questionnaire.
The researcher wants it for a study already completed. So they are not looking for the perfect measure, they just want to be able to cite one or more existing papers. The Rituximab study I found I'm guessing isn't going to be suitable as it is only part of the measure.
A researcher has asked me: does anyone know of any ME/CFS trials that have used a measure of post-exertional malaise as an outcome measure apart from the PACE Trial*
*Aside: which published a yes/no measure (they had used a Likert scale but published a yes/no result)
Edited to Add: The...
[Applause]
Thanks. I want to link to it so have copied it into this message:
my grandfather was a war hero he flew planes across into France and on secret missions to pick up spies and resistance fighters because they were secret he needed to land his plane by moonlight sometimes lit by torches...
If patients were given information about possible adverse effects or simply that it may not work, they might stop earlier when less harm had been done (or in some cases never start).
However, unlike with drug therapies, information on possible adverse effects is generally not given with...
(continued)
DR. KLIMAS: Factor analysis on the cluster?
DR. REEVES: I can't give you a great explanation yet because I
barely understand it, but if it works, I promise to explain it
thoroughly at the next meeting.
Just to quickly finish, in addition to our open-ended --...
I don't think some of these findings were ever published.
I'm clearing out some of the mass of paper I have and thought I should highlight it somewhere
https://listserv.nodak.edu/cgi-bin/wa.exe?A2=ind0910C&L=CO-CURE&P=R2735
CFSCC meeting, on April 22 (1999).
DR. REEVES: The...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.